According to Solid Biosciences 's latest financial reports the company's total assets are $0.16 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.16 B | -36.62% |
2022-12-31 | $0.26 B | 11.99% |
2021-12-31 | $0.23 B | 35.76% |
2020-12-31 | $0.17 B | 65.43% |
2019-12-31 | $0.10 B | -25.88% |
2018-12-31 | $0.13 B | 83.21% |
2017-12-31 | $76.19 M | 87.5% |
2016-12-31 | $40.63 M | -27.04% |
2015-12-31 | $55.69 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 52.79% | ๐บ๐ธ USA |